August 24, 2007 - The market for skin ulcer treatments is expected to see solid growth over the next four years due to demographic shifts and new treatments such as negative wound pressure therapy, sending the market to $6.2 billion in 2011, according to the third edition of "Wound Care Markets: Volume I: Skin Ulcers," a new report by New York-based Kalorama Information.
The report states overall steady growth in the worldwide skin ulcer treatment market will likely come from new therapies that result in decreasing healing times and subsequent cost savings; a growing focus on special populations such as diabetics and the obese; the increasing elderly population; availability of new therapeutic techniques; and the recent focus on wound care products and prevention.
Mature skin treatment products such as anti-infectives, skin ulcer management, and pressure relief devices will continue to generate the majority of sales, but advancements in biotechnology, biomaterials, and tissue engineering are expected to drive growth during the forecast period. Additionally, negative pressure wound therapy — the use of vacuum pressure within a foam sponge and adhesive wrap which stimulates blood flow and promotes faster healing — is a segment expected to boost market sales with another dose of significant growth, estimated at 11.6 percent.
"Developments in treatments of skin ulcers have made tremendous strides in the last decade," said Mary Anne Crandall, author of the report. "New developments are providing the health care arena of today with some truly sophisticated, highly effective skin ulcer treatments. Revolutionary advances using tissue engineering, growth factors, animal-fetal-cell research, stem-cell research, and gene therapy may offer new hope to patients who experience acute and chronic skin ulcers."
"Wound Care Markets: Volume I: Skin Ulcers" covers the world wound care market for skin ulcers in the anti-infectives, skin ulcer management, moist dressings, negative pressure wound therapy, biological dressings, pressure relief, and miscellaneous treatments product segments. The report analyzes products in development and on the market, leading competitors, and current issues and trends.

For more information: www.KaloramaInformation.com.


Related Content

News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Radiology Imaging

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
News | Women's Health

Aug. 19, 2024 — GE HealthCare recently announced a collaboration with the University of California San Diego School of ...

Time August 29, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
Subscribe Now